# Exalys Therapeutics, Inc. — Form D

Exalys Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-10. The offering totals $25.0M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-04-10
- Form: D
- Accession: 0001382963-20-000075
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $4.0M
- Remaining: $21.0M
- Investors: 2
- Date of first sale: 2020-04-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364777

## Issuer

- Name: Exalys Therapeutics, Inc.
- CIK: 0001808911
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 12481 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Phone: (949) 422-9676

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Rick Orr | Director | San Diego, CA |
| Dennis Podlesak | Director | SAN DIEGO, CA |
| Brian Taylor Slingsby | Director | Minato-ku, Tokyo, M0 |
| Takeshi Taylor Takahashi | Director | San Diego, CA |
| Nicole Vitullo | Director | Atlanta, GA |
| Eckard Weber, M.D. | Director | Menlo Park, CA |
| Dennis Podlesak | Executive Officer | SAN DIEGO, CA |
| Lynne Rollins | Executive Officer | Los Angeles, CA |
| Michael Sanders | Executive Officer | Austin, TX |

## More

- [CIK 1808911 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1808911&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001382963-20-000075.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.